Evaluation of effect on dose due to displacement of bowel and target volume in SBRT treatment for oligorecurrent crastation sensitive prostate cancer patients. (December 2021) - la Fauci, F.; Marvaso, G.; Augugliaro, M.; Comi, S.; Pepa, M.; Zaffaroni, M.; Corrao, G.; Mistretta, F.A.; Gandini, S.; Petralia, G.; Cattani, F.; de Cobelli, O.; et al.